These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28972487)

  • 1. EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM.
    Kolesnikova E; Potapenko A
    Georgian Med News; 2017 Sep; (270):69-75. PubMed ID: 28972487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders.
    Feisa SV; Chopei IV
    Wiad Lek; 2018; 71(2 pt 1):261-264. PubMed ID: 29729151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
    Zhaldak DA; Melekhovets OK; Orlovskyi VF
    Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.
    Perticone M; Cimellaro A; Maio R; Caroleo B; Sciacqua A; Sesti G; Perticone F
    Int J Mol Sci; 2016 Mar; 17(4):456. PubMed ID: 27023537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
    Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
    Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NON-ALCOHOLIC FATTY LIVER DISEASE IN ELDERLY.
    Krivosheev AB; Kuimov AD; Popov KV; Kondratova MA; Tuguleva TA; BoGoryanova PA
    Eksp Klin Gastroenterol; 2016; (9):27-31. PubMed ID: 29889391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
    Simon TG; Corey KE; Chung RT; Giugliano R
    Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity severity index as a new tool for assessment of co-existing diseases in patients with non-alcoholic fatty liver disease at the carbohydrate metabolism disorder background and concomitant subclinical hypothyroidism.
    Feysa SV; Chopei IV
    Wiad Lek; 2019; 72(4):650-653. PubMed ID: 31055550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD.
    Mavromati M; Jornayvaz FR
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
    Bhatt SP; Misra A; Nigam P; Guleria R; Pasha MA
    PLoS One; 2015; 10(11):e0142260. PubMed ID: 26599361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease.
    Lefere S; Van de Velde F; Devisscher L; Bekaert M; Raevens S; Verhelst X; Van Nieuwenhove Y; Praet M; Hoorens A; Van Steenkiste C; Van Vlierberghe H; Lapauw B; Geerts A
    Int J Obes (Lond); 2017 Aug; 41(8):1207-1213. PubMed ID: 28461687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
    Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
    Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease.
    Dawson AJ; Sathyapalan T; Smithson JA; Vince RV; Coady AM; Ajjan R; Kilpatrick ES; Atkin SL
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):843-9. PubMed ID: 23746214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical inflammation in relation to insulin resistance in prediabetic subjects with nonalcoholic fatty liver disease.
    Hossain IA; Akter S; Bhuiyan FR; Shah MR; Rahman MK; Ali L
    BMC Res Notes; 2016 May; 9():266. PubMed ID: 27169860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and metabolic features of nonalcoholic fatty liver disease in men and women].
    Krivosheev AB; Kuimov AD; Bogoryanova PA; Kondratova MA; Kupriyanova LY; Popov KV; Tuguleva TA
    Ter Arkh; 2017; 89(2):45-51. PubMed ID: 28281515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.